Hence, Nf levels (in particular NfL) might be particularly sensitive to neuronal decay in the early disease stage of SCA3, where biomarkers for tracking disease intensity would be most needed given the absence of change‐sensitive clinical parameters. Here, NFASC is linked to Spinocerebellar ataxia type 3.